Necrosis as a prognostic factor in glioblastoma multiforme

Cancer

Volumn 77, Issue 6, 1996, Pages 1161-1166

  Barker II, Fred G ^a,b   Davis, Richard L ^b   Chang, Susan M ^b   Prados, Michael D ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anaplastic astrocytoma; glioblastoma multiforme; necrosis; prognostic factors; survival analysis

Indexed keywords

CARMUSTINE; EFLORNITHINE; HYDROXYUREA; TIOGUANINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CELL PROLIFERATION; ENDOTHELIUM CELL; FEMALE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR NECROSIS;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NECROSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0029923502     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960315)77:6<1161::AID-CNCR24>3.0.CO;2-Z     Document Type: Article

References (35)

1. Tooth HH. Some observations on the growth and survival-period of intracranial tumours, based on the records of 500 cases, with special reference to the pathology of the gliomata. Brain 1912;35:61-108.
2. Bailey P, Cushing H. A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis. Philadelphia:J.B. Lippincott Co., 1926.
3. Ringertz N. "Grading" of gliomas. Acta Pathol Microbiol Scand 1950;29:51-64.
4. Kleihues P, Burger PC, Scheithauer BW. Histologic typing of tumours of the central nervous system. Berlin:Springer-Verlag, 1993.
5. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma mul tiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 1985;56:1106-11.
6. Nelson JS, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J, Peress N. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 1983;52:550-4.
7. Zülch KJ. Histologic typing of tumours of the central nervous system. Geneva:World Health Organization, 1979.
8. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;62:2152-65.
9. Daumas-Duport C, Szikla G. Délimitation et configuration spatiale des gliomes cérébraux. Données histologiques, incidences thérapeutiques. Neurochirurgie 1981;27:273-84.
10. Kernohan JW, Sayre GP. Tumors of the central nervous system. Washington, DC:Armed Forces Institute of Pathology, 1952.
11. Svien HJ, Mabon RF, Kernohan JW, Adson AW. Astrocytomas. Proc Staff Meet Mayo Clin 1949;24:55-64.
12. Kim TS, Halliday AL, Hedley-White ET, Convery K. Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg 1991;74:27-37.
13. Revesz T, Scaravilli F, Coutinho L, Cockburn H, Sacares P, Thomas DG. Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. Brain 1993;116:781-93.
14. Wang H-C, Ho Y-S. Clinicopathological evaluation of 78 astrocytomas in Taiwan with emphasis on a simple grading system. J Neurooncol 1992;13:265-76.
15. Rougier A, Dartigues JF, Cohadon F. Supratentorial gliomas: multivariate analysis of prognostic factors. In: Chalet M, Darcel F, Pecker J, editors. Brain oncology. Dordrecht:Martinus Nijhoff, 1987:249-51.
16. Cohadon F, Aouad N, Rougier A, Vital C, Rivel J, Dartigues JF. Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors. J Neurooncol 1985;3:105-11.
17. Alvord EC Jr. Is necrosis helpful in the grading of gliomas? Editorial opinion. J Neuropath Exp Neurol 1992;51:127-32.
18. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987;59:1617-25.
19. Davis RL, Liu HC, Vestnys P, Resser KJ, Levin VA. Correlation of survival and diagnosis in supratentorial malignant gliomas [abstract]. J Neurooncol 1984;2:267.
20. Russell DS, Rubinstein LJ. Pathology of tumors of the central nervous system. 5th edition. Baltimore:Williams and Wilkins, 1989.
21. Sprent P. Applied nonparametric statistical methods. London:Chapman & Hall, 1993.
22. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986;105:429-35.
23. Machin D, Gardner MJ. Calculating confidence intervals for survival time analyses. In: Gardner MJ, Altman DG, editors. Statistics with confidence. London:British Medical Journal, 1989:64-70.
24. Cox DR. Regression models and life tables. J R Scat Soc [Ser B] 1972;34:187-220.
25. Harris EK, Albert A. Survivorship analysis for clinical studies. New York: Marcel Dekker, 1991.
26. Lee ET. Statistical methods for survival data analysis. New York:John Wiley & Sons, 1992.
27. Barker FG, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, et al. Radiation response and survival in patients with glioblastoma multiforme. J Neurosurg. In press.
28. Glantz MJ, Burger PC, Herndon JE 2d, Friedman AH, Cairncross JG, Vick NA, et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991;41:1741-44.
29. Chandrasoma FT, Smith MM, Apuzzo ML. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 1989;24:160-5.
30. Prados MD, Gutin PH, Phillips TL, Wara WM, Larson DA, Sneed PK, et al. Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 1992;23:3-8.
31. Levin VA, Prados MD, Wara WM, Davis RL, Gutin PH, Phillips TL, et al. Radiation therapy and biomodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 1995;32:75-83.
32. Nelson DF, Nelson JS, Davis DR, Chang CH, Griffin TW, Pajak TF. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J Neurooncol 1985;3:99-103.
33. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Nelson DF, et al. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol 1992;12:219-27.
34. Fulling KH, Garcia DM. Anaplastic astrocytoma of the adult cerebrum: prognostic value of histologic features. Cancer 1985;55:928-31.
35. Schiffer D, Chiò A, Giordana MT, Leone M, Soffietti R. Prognostic value of histologic factors in adult cerebral astrocytoma. Cancer 1988;61:1386-93.